The marijuana stock market recently saw a decline in value for some of the most prominent companies in the industry. This can be attributed to various bouts of news hitting the market, but more importantly to the infancy and subsequent volatility of the industry as a whole. Although it seems as though the volatility is never-ending, it’s clear that this is all due to how new the industry is as a whole. The trading day on Friday, November 16th showed a slowing of this volatility that will hopefully signal a changing pace in the market that can stay for years to come. All of this, however, is in due time, but for now, marijuana seems to continue to be one of the most intriguing markets of the modern day.
Tidal Royalty Corp. (OTC:RLTY) has been one of the prominent players in the marijuana market for some time now. The company recently stated that they will begin to offer $10 million in financing to license the company Harborside. Tidal Royalty has been known as one of the most important financiers in the cannabis industry and has been working to secure partnerships with various cannabis producers and exporters throughout the space. The terms of this new deal show that “Tidal Royalty will provide US$10 million in financing to prospective dispensary operators licensing the Harborside brand. Each potential financing transaction for dispensaries will be evaluated on a case-by-case basis and specific financing terms will be negotiated between the companies.” The CEO of Tidal Royalty, Paul Rosen stated that “Harboside is one of the preeminent cannabis companies in the U.S. Through our strategic financing partnership, Tidal Royalty would provide select operators with the capital required to launch a dispensary licensing the “Harborside” brand in exchange for a royalty on sales.” The hopes are high that Tidal can continue on their way to becoming one of the most important financiers in the cannabis market.
GW Pharmaceuticals (NASDAQ:GWPH) should be a household name at this point for anyone who knows anything about the marijuana stock space. The company saw recent fame after introducing the drug Epidiolex, which became the first drug derived from marijuana to be approved by the FDA. The drug, however, does not contain any THC, but rather works by using cannabidiol or CBD which is the non-psychoactive component of the plant. This means that the drug can be used in children or those who cannot stand to have any psychoactive effects. The company has remained one of the most important cannabis stocks in the space because they represent the top of the biotech sector within the industry. The hopes, however, are that in the U.S., the government can begin to delist cannabis as a Schedule I narcotic which can then open the doors to allow more and more companies to get into the biotech space with cannabis.
The cannabis market has remained one of the most important markets of the modern day, but with volatility still high, it seems as though investors should be looking at the long-term for growth.
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Tidal Royalty Corp, Midam is being paid $150,000 for a period of 30 days beginning October 1, 2018 and ending November 1, 2018. We own 0 shares of Tidal Royalty Corp. We may buy or sell additional shares of (TDRYF/RLTY.CN) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Tidal Royalty Corp
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers